Sanj K Patel's Net Worth
$49.1 Million
Who is Sanj K Patel?
Sanj K Patel has an estimated net worth of $49.1 Million. This is based on reported shares across multiple companies, which include Kiniksa Pharmaceuticals, Ltd., INTERCEPT PHARMACEUTICALS INC, BIOCRYST PHARMACEUTICALS INC, Syros Pharmaceuticals, Inc., and SYNAGEVA BIOPHARMA CORP.
SEC CIK
Sanj K Patel's CIK is 0001532218
Past Insider Trading and Trends
2013 was Sanj K Patel's most active year for acquiring shares with 19 total transactions. Sanj K Patel's most active month to acquire stocks was the month of August. 2013 was Sanj K Patel's most active year for disposing of shares, totalling 36 transactions. Sanj K Patel's most active month to dispose stocks was the month of November. 2018 saw Sanj K Patel paying a total of $999,982.98 for 753,014 shares, this is the most they've acquired in one year. In 2020 Sanj K Patel cashed out on 436,259 shares for a total of $5,950,312.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $18.15
CHAIRMAN & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.36% | 5.92K |
$17.90 | -$72,942.50 | 63.01K |
Apr 4 - Apr 8
| |||
Form 4
| +8.72% | 4.58K |
$19.70 | -$37,489.10 | 57.09K |
Apr 1
| |||
Form 4
| -100.00% | -65.01K |
$21.02 | -$1,366,552.24 |
0
|
Scheduled
|
Mar 7
| ||
Form 4
| -21.99% | -18.32K |
$21.34 | -$391,055.86 | 65.01K |
Scheduled
|
Mar 4 - Mar 6
| ||
Form 4
| +23.35% | 9.94K |
$17.76 | -$117,553.44 | 52.52K |
Sep 1 - Sep 2
| |||
Form 4
| +19.88% | 7.06K |
$10.71 | -$31,412.43 | 42.57K |
Apr 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| +58.58% | 13.12K |
$11.24 | -$61,282.10 | 35.52K |
Mar 16 - Mar 20
| |||
Form 4
| +26.13% | 4.64K |
$11.44 | -$22,067.76 | 22.4K |
Sep 1 - Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 7
| |||
Form 4
| +282.10% | 13.11K |
$10.98 | -$59,797.08 | 17.76K |
Mar 21
| |||
Form 4
|
∞
| 4.65K |
$10.13 | -$19,469.86 | 4.65K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
| -25.97% | -29.23K |
$12.32 | -$1,251,723.40 | 83.34K |
Scheduled
|
Feb 8 - Feb 10
| ||
Form 4
| -47.04% | -100.00K |
$11.31 | -$5,047,013.12 | 112.57K |
Scheduled
|
Oct 9 - Oct 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
| -13.48% | -33.12K |
$20.00 | -$662,300.00 | 212.57K |
Scheduled
|
Mar 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 4
| +123.76% | 135.89K |
—
|
—
| 245.69K |
Feb 9 - May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTERCEPT PHARMACEUTICALS INC (ICPT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 452 |
—
|
—
| 452 |
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOCRYST PHARMACEUTICALS INC (BCRX) Snapshot price: $5.31
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $7.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SYNAGEVA BIOPHARMA CORP No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -73.32K |
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +6,983.51% | 72K |
—
|
—
| 73.03K |
Jun 5
| |||
Form 4
|
—
|
0
|
$52.07 | -$3,678,391.76 | 1.03K |
Scheduled
|
Dec 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
$45.56 | -$8,707,706.57 | 1.03K |
Scheduled
|
Jan 28 - Jan 29
| ||
Form 4
|
—
|
0
|
$25.28 | -$4,547,426.01 | 1.03K |
Scheduled
|
Jul 25 - Jul 29
| ||
Form 4
|
—
|
0
|
$20.88 | -$2,768,207.43 | 1.03K |
Scheduled
|
Jun 11 - Jun 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
$25.32 | -$1,540,250.90 | 1.03K |
Scheduled
|
Apr 5 - Apr 8
| ||
Form 4
|
—
|
0
|
$25.93 | -$1,918,067.12 | 1.03K |
Scheduled
|
Apr 3 - Apr 4
| ||
Form 4
|
—
|
0
|
$25.07 | -$3,377,120.70 | 1.03K |
Scheduled
|
Feb 20 - Feb 21
| ||
Form 4
|
—
|
0
|
$23.58 | -$2,715,437.58 | 1.03K |
Scheduled
|
Dec 13 - Dec 17
| ||
Form 4
|
—
|
0
|
$24.94 | -$1,678,855.10 | 1.03K |
Scheduled
|
Dec 4 - Dec 5
| ||
Form 4
|
—
|
0
|
$25.15 | -$1,693,568.00 | 1.03K |
Scheduled
|
Nov 30 - Dec 3
| ||
Form 4
|
—
|
0
|
$25.21 | -$3,396,390.80 | 1.03K |
Scheduled
|
Aug 31 - Sep 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
$18.14 | -$1,718,818.08 | 1.03K |
Scheduled
|
Jun 1 - Jun 4
| ||
Form 4
|
—
|
0
|
$17.24 | -$1,628,910.00 | 1.03K |
Scheduled
|
Mar 23
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||